Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)
Stopped early · Phase 2 · Has a placebo group
Conditions studied: Idiopathic Interstitial Pneumonias / Hypertension,Pulmonary
In brief
To evaluate the efficacy and safety of 26-weeks of treatment with riociguat vs. placebo in patients with symptomatic PH (pulmonary hypertension) associated with IIP (idiopathic interstitial pneumonias).
Key facts
- Study ID
- NCT02138825
- Run by
- Bayer
- People needed
- 147
- Starts
- 2014-06-04
- Expected to finish
- 2016-09-14
- Last updated by the study team
- 2017-12-04
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Study site — San Francisco, California, United States
- Study site — Aurora, Colorado, United States
- Study site — Miami, Florida, United States
- Study site — Orlando, Florida, United States
- Via Christi Clinic — Wichita, Kansas, United States
- Study site — Louisville, Kentucky, United States
- Columbia University Medical Center — New York, New York, United States
- Study site — Durham, North Carolina, United States
- Study site — Cincinnati, Ohio, United States
- Study site — Cleveland, Ohio, United States
- Study site — Columbus, Ohio, United States
- Study site — Portland, Oregon, United States
- Study site — Pittsburgh, Pennsylvania, United States
- Study site — Nashville, Tennessee, United States
- Study site — Dallas, Texas, United States
- Study site — Falls Church, Virginia, United States
- Study site — Mar del Plata, Buenos Aires, Argentina
- Study site — Buenos Aires, Ciudad Auton. de Buenos Aires, Argentina
- Study site — Buenos Aires, Ciudad Auton. de Buenos Aires, Argentina
- Study site — Godoy Cruz, Mendoza Province, Argentina
- Study site — San Miguel de Tucumán, Tucumán Province, Argentina
- Study site — Camperdown, New South Wales, Australia
- Study site — Darlinghurst, New South Wales, Australia
- Study site — Sydney, New South Wales, Australia
- University of California, Los Angeles — Los Angeles, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.